-begron
Drugs that activate beta-3 adrenergic receptors, used for overactive bladder.
- Drugs ending in -begron: 6
- Approved somewhere: 2
- With a US drug page: 2
- Stem
- -begron
- Class
- Drugs that activate beta-3 adrenergic receptors, used for overactive bladder
- Most common targets
- ADRB3 (6)
Approved and clinical-stage drugs in ChEMBL whose names ending in -begron, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Mirabegron | Approved | ADRB3 | Beta-3 adrenergic receptor agonist |
| Vibegron | Approved | ADRB3 | Beta-3 adrenergic receptor agonist |
| Amibegron | Phase 3 | ADRB3 | Beta-3 adrenergic receptor agonist |
| Ritobegron | Phase 3 | ADRB3 | Beta-3 adrenergic receptor agonist |
| Solabegron | Phase 2 | ADRB3 | Beta-3 adrenergic receptor agonist |
| Rafabegron | — | ADRB3 | Beta-3 adrenergic receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO